Früh- und Differenzialdiagnose der Creutzfeldt-Jakob Krankheit[¹]

Literatur

• 1 Bieschke J, Giese A, Schulz-Schaeffer W. et al . Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets.  PNAS. 2000;  97 5468-5473
• 2 Brown P. EEG findings in Creutzfeldt-Jakob disease.  JAMA. 1993;  269 3168
• 3 Brown P, Gibbs C J, Rodgers-Johnson P. et al . Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.  Ann Neurol. 1994;  35 513-529
• 4 Finkenstaedt M, Szudra A, Zerr I. et al . MR imaging of Creutzfeldt-Jakob disease.  Radiology. 1996;  199 793-798
• 5 Gertz H J, Henkes H, Cervos N J. Creutzfeldt-Jakob disease: correlation of MRI and neuropathologic findings.  Neurology. 1988;  38 1481-1482
• 6 Harrington M G, Merril C R, Asher D M, Gajdusek D C. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.  N Engl J Med. 1986;  315 279-283
• 7 Hsich G, Kenney K, Gibbs C J, Lee K H, Harrington M G. The 14 - 3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.  N Engl J Med. 1996;  335 924-930
• 8 Jacobi C, Zerr I, Arlt S, Schröter A, Otto M, Poser S. Cerebrospinal fluid pattern in patients with definite Creutzfeldt-Jakob disease.  J Neurol. 2000;  247 III/14
• 9 Jacobi C, Zerr I, Arlt S, Schröter A, Otto M, Poser S. Virusspezifische Antikörper bei der Creutzfeldt-Jakob-Erkrankung.  Akt Neurol. 2000;  27 S109
• 10 Jimi T, Wakayama Y, Shibuya S. et al . High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease.  Clin Chim Acta. 1992;  211 37-46
• 11 Kretzschmar H A, Ironside J W, DeArmond S J, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.  Arch Neurol. 1996;  53 913-920
• 12 Kropp S, Finkenstaedt M, Zerr I, Schroter A, Poser S. Diffusionsgewichtetes MRT bei Creutzfeldt-Jakob-Patienten.  Nervenarzt. 2000;  71 91-95
• 13 Levy S R, Chiappa K H, Burke C J, Young R R. Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease.  J Clin Neurophysiol. 1986;  3 1-21
• 14 Link H, Kostulas V. Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.  Clin Chem. 1983;  29 810-815
• 15 Lopez O L, Litvan I, Catt K E. et al . Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.  Neurology. 1999;  53 1292-1299
• 16 Masters C L, Harris J O, Gajdusek D C, Gibbs C JJ, Bernoulli C, Asher D M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.  Ann Neurol. 1979;  5 177-188
• 17 Otto M, Wiltfang J, Schütz E. et al . Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study.  BMJ. 1998;  316 577-582
• 18 Otto M, Wiltfang J, Tumani H. et al . Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.  Neurosci Lett. 1997;  225 210-212
• 19 Parchi P, Giese A, Capellari S. et al . Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.  Ann Neurol. 1999;  46 224-233
• 20 Poser S, Mollenhauer B, Krauß A. et al . How to improve the clinical diagnosis of Creutzfeldt-Jakob disease.  Brain. 1999;  122 2345-2351
• 21 Röther J, Schwartz A, Harle M, Wentz K U, Berlit P, Hennerici M. Magnetic resonance imaging follow-up in Creutzfeldt-Jakob disease.  J Neurol. 1992;  239 404-406
• 22 Samman I, Schulz-Schaeffer W J, Wohrle J C, Sommer A, Kretzschmar H A, Hennerici M. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.  J Neurol Neurosurg Psychiatry. 1999;  67 678-681
• 23 Schmerr M J, Jenny A L, Bulgin M S. et al . Use of capillary electrophoresis and fluorescent labeled peptides to detect abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy.  J Chromatogr A. 1999;  853 207-214
• 24 Schröter A, Zerr I, Henkel K, Tschampa H J, Finkenstaedt M, Poser S. Magnetic resonance imaging (MRI) in the clinical diagnosis of Creutzfeldt-Jakob disease.  Arch Neurol. 2000;  57 1751-1757
• 25 Seipelt M, Zerr I, Nau R. et al . Hashimoto encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease.  J Neurol Neurosurg Psychiatry. 1999;  66 172-176
• 26 Steinhoff B J, Kropp S, Riedemann C, Eckardt K M, Herrendorf G, Poser S. Elektroenzephalographische Charakteristika der Creutzfeldt-Jakobschen Krankheit und ihre Differentialdiagnose.  Fortschr Neurol Psychiatr. 1998;  66 357-365
• 27 Steinhoff B J, Räcker S, Herrendorf G. et al . Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease.  Arch Neurol. 1996;  53 162-166
• 28 Tartaro A, Fulgente T, Delli-Pizzi C, Bonomo L, Bocola V, Onofrj M. MRI alterations as an early finding in Creutzfeld-Jakob disease.  Eur J Radiol. 1993;  17 155-158
• 29 Tourtellotte W W. The cerebrospinal fluid in multiple sclerosis. Amsterdam: Elsevier Science Publishers In: Vinken PJ, Bruyn GW, Klawans HL. Handbook of Clinical Neurology 1985: 79-130
• 30 Tschampa H J, Neumann M, Zerr I. et al . Patients with Alzheimer’s disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease.  J Neurol Neurosurg Psychiatry. 2001;  71 33-39
• 31 Urbach H, Klisch J, Wolf H K, Brechtelsbauer D, Gass S, Solymosi L. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data.  Neuroradiology. 1998;  40 65-70
• 32 Urbach H, Paus S, Tschampa H J, Keller E, Schild H H. Creutzfeldt-Jakob-Krankheit: Stellenwert der MRT.  Fortschr Röntgenstr. 2001;  173 509-514
• 33 Verghese J, Crystal H A, Dickson D W, Lipton R B. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies.  Neurology. 1999;  53 1974-1982
• 34 Verity C M, Nicoll A, Will R G, Devereux G, Stellitano L. Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study.  Lancet. 2000;  356 1224-1227
• 35 WHO . Human transmissible spongiform encephalopathies.  Weekly Epidemiological Record. 1998;  47 361-365
• 36 Will R G, Zeidler M, Stewart G E. et al . Diagnosis of new variant Creutzfeldt-Jakob disease.  Ann Neurol. 2000;  47 575-582
• 37 Zeidler M, Sellar R J, Collie D A. et al . The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease.  Lancet. 2000;  355 1412-1418
• 38 Zerr I, Bodemer M, Gefeller O. et al . Detection of 14 - 3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.  Ann Neurol. 1998;  43 32-40
• 39 Zerr I, Bodemer M, Otto M. et al . Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.  Lancet. 1996;  348 846-849
• 40 Zerr I, Bodemer M, Räcker S. et al . Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.  Lancet. 1995;  345 1609-1610
• 41 Zerr I, Bodemer M, Westermann R. et al . 14 - 3-3 proteins in neurological disorders.  J Neurol. 2000;  247 III/14
• 42 Zerr I, Pocchiari M, Collins S. et al . Analysis of EEG and CSF 14 - 3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.  Neurology. 2000;  55 811-815
• 43 Zerr I, Schulz-Schaeffer W J, Giese A. et al . Current clinical diagnosis in CJD: identification of uncommon variants.  Ann Neurol. 2000;  48 323-329

1 Die Studie wird durchgeführt durch fortlaufende finanzielle Unterstützung des Bundesministeriums für Gesundheit (Az 325-4471-02/15) und Förderung der Europäischen Union (BIO4-98-3727).

Korrespondenz